Cargando…

RefineNet-based automatic delineation of the clinical target volume and organs at risk for three-dimensional brachytherapy for cervical cancer

BACKGROUND: In recent years, high-precision image-guided intensity-modulated radiation therapy combined with three-dimensional (3D) high-dose-rate (HDR) brachytherapy (BT) has become a recommended technique for radical radiotherapy for cervical cancer. This study first employed contrast-limited adap...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Xue, Wang, Fang, Chen, Ying, Yan, Senxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743698/
https://www.ncbi.nlm.nih.gov/pubmed/35071415
http://dx.doi.org/10.21037/atm-21-4074
_version_ 1784629962890805248
author Jiang, Xue
Wang, Fang
Chen, Ying
Yan, Senxiang
author_facet Jiang, Xue
Wang, Fang
Chen, Ying
Yan, Senxiang
author_sort Jiang, Xue
collection PubMed
description BACKGROUND: In recent years, high-precision image-guided intensity-modulated radiation therapy combined with three-dimensional (3D) high-dose-rate (HDR) brachytherapy (BT) has become a recommended technique for radical radiotherapy for cervical cancer. This study first employed contrast-limited adaptive histogram equalization (CLAHE) for preprocessing of input data to achieve image enhancement. In this way, rapid and accurate automatic delineation of the clinical target volume (CTV) and organs at risk (OARs) in 3D BT for cervical cancer was achieved. METHODS: Two hundred cervical cancer patients who underwent radical radiotherapy from January 2016 to December 2018 were selected. After collecting the computed tomography (CT) image data of a patient, we constructed the radiotherapy CTV and OAR image libraries. A RefineNet-based deep learning protocol was used to segment the CTV and OARs for 3D BT for cervical cancer. In this study, a total of 1,000 rounds of training were carried out, and the model with the best performance was selected for subsequent iterative tuning. Finally, the clinical test was carried out, in which the CT images of 10 cases were tested one by one. The manual delineation results and the model output results for the CTV and OARs were compared to measure the performance of the model. RESULTS: Compared with the manually delineated CTV, the RefineNet model-based segmented CTV had a higher Dice similarity coefficient (DSC), Hausdorff distance (HD), and overlap index (OI), which were 0.861, 6.005, and 0.839, respectively. For OARs, the RefineNet-based model obtained the best results for bladder segmentation (DSC: 85.96%), respectively. The mean duration of RefineNet-based automatic contour processing of the CTV was 70 s, and the mean durations of RefineNet-based automatic delineation of the bladder, rectum, sigmoid colon, and small intestine were 67, 67.4, 63.8, and 60.8 s, respectively. The total time saved by RefineNet was approximately 60%. CONCLUSIONS: The RefineNet-based automatic delineation model for 3D BT for cervical cancer is a stable and highly consistent automatic delineation algorithmic model that has the potential to improve the consistency of target region delineation, simplify the radiotherapy procedure, and achieve rapid and accurate automatic delineation of CTVs and OARs.
format Online
Article
Text
id pubmed-8743698
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-87436982022-01-21 RefineNet-based automatic delineation of the clinical target volume and organs at risk for three-dimensional brachytherapy for cervical cancer Jiang, Xue Wang, Fang Chen, Ying Yan, Senxiang Ann Transl Med Original Article BACKGROUND: In recent years, high-precision image-guided intensity-modulated radiation therapy combined with three-dimensional (3D) high-dose-rate (HDR) brachytherapy (BT) has become a recommended technique for radical radiotherapy for cervical cancer. This study first employed contrast-limited adaptive histogram equalization (CLAHE) for preprocessing of input data to achieve image enhancement. In this way, rapid and accurate automatic delineation of the clinical target volume (CTV) and organs at risk (OARs) in 3D BT for cervical cancer was achieved. METHODS: Two hundred cervical cancer patients who underwent radical radiotherapy from January 2016 to December 2018 were selected. After collecting the computed tomography (CT) image data of a patient, we constructed the radiotherapy CTV and OAR image libraries. A RefineNet-based deep learning protocol was used to segment the CTV and OARs for 3D BT for cervical cancer. In this study, a total of 1,000 rounds of training were carried out, and the model with the best performance was selected for subsequent iterative tuning. Finally, the clinical test was carried out, in which the CT images of 10 cases were tested one by one. The manual delineation results and the model output results for the CTV and OARs were compared to measure the performance of the model. RESULTS: Compared with the manually delineated CTV, the RefineNet model-based segmented CTV had a higher Dice similarity coefficient (DSC), Hausdorff distance (HD), and overlap index (OI), which were 0.861, 6.005, and 0.839, respectively. For OARs, the RefineNet-based model obtained the best results for bladder segmentation (DSC: 85.96%), respectively. The mean duration of RefineNet-based automatic contour processing of the CTV was 70 s, and the mean durations of RefineNet-based automatic delineation of the bladder, rectum, sigmoid colon, and small intestine were 67, 67.4, 63.8, and 60.8 s, respectively. The total time saved by RefineNet was approximately 60%. CONCLUSIONS: The RefineNet-based automatic delineation model for 3D BT for cervical cancer is a stable and highly consistent automatic delineation algorithmic model that has the potential to improve the consistency of target region delineation, simplify the radiotherapy procedure, and achieve rapid and accurate automatic delineation of CTVs and OARs. AME Publishing Company 2021-12 /pmc/articles/PMC8743698/ /pubmed/35071415 http://dx.doi.org/10.21037/atm-21-4074 Text en 2021 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Jiang, Xue
Wang, Fang
Chen, Ying
Yan, Senxiang
RefineNet-based automatic delineation of the clinical target volume and organs at risk for three-dimensional brachytherapy for cervical cancer
title RefineNet-based automatic delineation of the clinical target volume and organs at risk for three-dimensional brachytherapy for cervical cancer
title_full RefineNet-based automatic delineation of the clinical target volume and organs at risk for three-dimensional brachytherapy for cervical cancer
title_fullStr RefineNet-based automatic delineation of the clinical target volume and organs at risk for three-dimensional brachytherapy for cervical cancer
title_full_unstemmed RefineNet-based automatic delineation of the clinical target volume and organs at risk for three-dimensional brachytherapy for cervical cancer
title_short RefineNet-based automatic delineation of the clinical target volume and organs at risk for three-dimensional brachytherapy for cervical cancer
title_sort refinenet-based automatic delineation of the clinical target volume and organs at risk for three-dimensional brachytherapy for cervical cancer
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743698/
https://www.ncbi.nlm.nih.gov/pubmed/35071415
http://dx.doi.org/10.21037/atm-21-4074
work_keys_str_mv AT jiangxue refinenetbasedautomaticdelineationoftheclinicaltargetvolumeandorgansatriskforthreedimensionalbrachytherapyforcervicalcancer
AT wangfang refinenetbasedautomaticdelineationoftheclinicaltargetvolumeandorgansatriskforthreedimensionalbrachytherapyforcervicalcancer
AT chenying refinenetbasedautomaticdelineationoftheclinicaltargetvolumeandorgansatriskforthreedimensionalbrachytherapyforcervicalcancer
AT yansenxiang refinenetbasedautomaticdelineationoftheclinicaltargetvolumeandorgansatriskforthreedimensionalbrachytherapyforcervicalcancer